This website provides information on patients with mutations in the CD55 gene, including clinical data, molecular data, management and research options.

The syndrome caused by mutations in the CD55 gene is a multisystem disorder characterized by protein-losing enteropathy associated with intestinal lymphangiectasia and susceptibility to venous thrombosis (OMIM #26300). Not all individuals with mutations in the CD55 gene have these features; there is certain phenotypic heterogeneity among CD55-deficiency patients.

This website was created to share and collect information about clinic, management and research projects to gather more knowledge and provide better treatment of patients with mutations in the CD55 gene.

Alina Kurolap, RN, MSc, The Genetics Institute, Rambam Health Care Campus, Haifa, Israel, a_kurolap@rambam.health.gov.il

Hagit Baris Feldman, MD, The Genetics Institute, Rambam Health Care Campus, Haifa, Israel, hb_feldman@rambam.health.gov.il